H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
2026 · 3rd Quarter (July 1 - Sep 30)
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Filed by BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.).
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- Not reported
- Expenses
- $150,000.00
- Filing UUID
- 3ef93c2d-a5af-454f-b249-e890d4e1eef9
- Termination date
- Not reported
Expense method: B
Literal source text
Lobbying issues and bill citations
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.
Literal federal measure citations: H.R. 10227, S. 4189, S. 4612, H.R. 9000, S. 8270, H.R. 8018
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.